Abstract

BackgroundAlterations in surfactant phospholipid compositions are a recognized feature of many acute and chronic lung diseases. Investigation of underlying mechanisms requires assessment of surfactant phospholipid molecular composition and kinetics of synthesis and turnover. Such studies have recently become possible in humans due to the development of stable isotope labelling combined with advances in analytical methods in lipidomics. The objectives of this study are to compare phospholipid molecular species composition and phosphatidylcholine synthesis and turnover in surfactant isolated from various endobronchial compartments in healthy adults.MethodsHealthy adults (N = 10) were infused with methyl-D9-choline chloride and samples of induced sputum, tracheal wash and small volume bronchoalveolar lavage fluid were obtained subsequently at intervals up to 96 hours. Surfactant phospholipid composition and incorporation of stable isotope into surfactant phosphatidylcholine were determined by electrospray ionisation mass spectrometry.ResultsWhile molecular species compositions of phospholipids were similar for all three sample types, dipalmitoylphosphatidylcholine content was highest in lavage, intermediate in tracheal wash and lowest in sputum. Methyl-D9-choline incorporation into surfactant phosphatidylcholine was lower for sputum at 24 hours but reached equilibrium with other sample types by 48 hours. Fractional methyl-D9-dipalmitoylphosphatidylcholine incorporation for all sample types was about 0.5% of the endogenous composition. Lysophosphatidylcholine enrichment was twice than that of phosphatidylcholine.ConclusionsTracheal secretions may be of value as a surrogate to assess bronchoalveolar lavage fluid surfactant molecular composition and metabolism in healthy people. Despite minor differences, the phospholipid molecular composition of induced sputum also showed similarities to that of bronchoalveolar lavage fluid. Detailed analysis of newly synthesized individual phosphatidylcholine species provided novel insights into mechanisms of surfactant synthesis and acyl remodelling. Lysophosphatidylcholine methyl-D9 incorporation patterns suggest that these species are secreted together with other surfactant phospholipids and are not generated in the air spaces by hydrolysis of secreted surfactant phosphatidylcholine. Application into patient populations may elucidate potential underlying pathophysiological mechanisms that lead to surfactant alterations in disease states.

Highlights

  • Alterations in surfactant phospholipid compositions are a recognized feature of many acute and chronic lung diseases

  • This study demonstrates for the first time the molecular compositions of various bronchoalveolar compartments in human model and the surfactant molecular PC kinetics from all these compartments

  • The results showed that surfactant extracted by tracheal wash (TW) closely resembled that of bronchoalveolar lavage fluid (BALF)

Read more

Summary

Introduction

Alterations in surfactant phospholipid compositions are a recognized feature of many acute and chronic lung diseases. PC, especially the disaturated dipalmitoyl species (PC16:0/16:0), is the major surface active component of surfactant phospholipid This stable isotope methodology enables the assessment of both the rate of synthesis and secretion of individual molecular species of surfactant PC and the specificity of fatty acyl remodelling mechanisms involved in their synthesis. This detailed analysis provides important information about mechanisms of surfactant PC synthesis and secretion, but comparison of fractional incorporation rates between sample types can demonstrate the time required for newly secreted alveolar surfactant to transit to the upper airways

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call